KL
Therapeutic Areas
AdAlta Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AD-214 | Fibrotic diseases (IPF, kidney fibrosis) | Phase 2 |
| WD-34 | Malaria prophylaxis (also babesiosis, toxoplasmosis) | Preclinical |
| CAR-T Lung | Solid Tumor – Lung Cancer | Phase 1 |
| CAR-T Colorectal | Solid Tumor – Colorectal Cancer | Phase 1 |
| CAR-T Gastric | Solid Tumor – Gastric Cancer | Phase 1 |